vimarsana.com

Page 3 - மருத்துவ ஆராய்ச்சி ஆர்கநைஸேஶந்ஸ் கிராஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Laboratory Informatics Market to Have A Promising Future Ahead! | FinancialContent Business Page

Empty Capsule Market Poised for Growth | Key Players –  Capsugel, Sunil Healthcare, Roxlor, ACG Worldwide, Medi-Caps – KSU

Empty Capsule Market Poised for Growth | Key Players –  Capsugel, Sunil Healthcare, Roxlor, ACG Worldwide, Medi-Caps – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.

Global Biotechnology Services Market Report 2020: Market to Grow at a CAGR of 5% from 2019 to 2020 Due to COVID-19 and Increase in R&D Activities

Share this article Share this article ResearchAndMarkets.com s offering. Biotechnology Services Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biotechnology services market. Major players in the biotechnology services market are Novartis, Fisher BioService, Pfizer, Novo Nordisk, BioAlps, Precision for Medicine, Sartorius and Aldevron. The global biotechnology services market is expected to increase from $142.92 billion in 2019 to $150.06 billion in 2020 at a compound annual growth rate (CAGR) of 5.0%. The growth is mainly due to the COVID-19 outbreak that has led to an increase in research and development activities. The market is expected to grow further and reach $210.96 billion in 2023 at a CAGR of 12.03%. Biotechnology services is the second-largest sector after biopharmaceuticals which is anticipated to emerge significantly due to increasing rese

CANKADO s Digital Health Solution Assists a New Clinical Trial, ADAPTlate

This oncologic clinical trial evaluates the efficacy and safety of the CDK 4/6 Inhibitor Abemaciclib in combination with endocrine therapy in high-risk early breast cancer patients Cologne, Germany, 07.01.2021 – CANKADO, the leading digital health application developers in Germany, assists the recently started clinical trial, ADAPTlate, organized by West German Study Group (WSG) to collect the Patient Reported Outcomes (PROs) by the CANKADO ePRO tool. The clinical trial already enrolled the first patients who are using the CANKADO e-Health system as part of the study to monitor their Quality of Life (QoL). The trial aims to gain further knowledge on the efficacy and safety of the Abemaciclib treatment in combination with endocrine therapy versus standard endocrine therapy in HR+/HER2- early breast cancer patients with high risk for disease recurrence.

CANKADO s Companion-APP Solution provides Drug-Optimised Digital Applications for Pharmaceutical Companies

The tool is a drug tailored extension of CANKADO’s e-Health solution Cologne, Germany, 17.12.2020 – CANKADO’s Companion-APP solution provides an environment that helps to build a drug-tailored digital connected care solution for physicians and their patients. Pharmaceutical companies can easily develop their own multi-dimensional drug-optimized digital support for every drug and treatment. It improves patient safety, increases patient compliance, and prolongs drug adherence for a better outcome. CANKADO Companion-APP is a complete solution comprising a family of medical devices according to EU and US regulations. It is built on CANKADO’s backbone structure that consists of patient’s records ensuring data security and privacy. It allows connection to healthcare professionals and includes the AI-driven PRO-React framework. Information extensions are integrated on Companion-APP, tailored for each drug/treatment. Pharma partners of CANKADO can build their own drug tailore

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.